Biofil Chemicals and Pharmaceuticals Limited (NSE:BIOFILCHEM)

NSE:BIOFILCHEM Revenue

Biofil Chemicals and Pharmaceuticals had revenue of 142.18M INR in the quarter ending December 31, 2024, with 182.59% growth. This brings the company's revenue in the last twelve months to 406.12M, up 5.63% year-over-year. In the fiscal year ending March 31, 2024, Biofil Chemicals and Pharmaceuticals had annual revenue of 404.09M with 34.54% growth.

• Revenue (ttm): 406.12M
• Revenue Growth: +5.63%
• P/S Ratio: 1.81
• Revenue / Employee: 15.62M
• Employees: 26
• Market Cap: 736.88M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	404.09M	103.74M	34.54%
Mar 31, 2023	300.35M	76.53M	34.19%
Mar 31, 2022	223.82M	-134.27M	-37.50%
Mar 31, 2021	358.10M	60.42M	20.30%
Mar 31, 2020	297.67M	66.01M	28.49%